These headings link you to the corresponding sections below |
Click Show Links to expand a section or sub-section |
|
  |
 |
Clinic Resources and Tools |
|
|
 |
 |
 |
Vaccine administration |
 |
 |
Clinical considerations for use
of COVID-19 vaccines |
 |
 |
Clinical care considerations |
 |
 |
Vaccine safety |
 |
 |
Vaccine storage and handling (includes temperature logs) |
 |
 |
Training materials for providers |
 |
 |
Administrative and operational
issues |
|
 |
Information about COVID-19 Vaccine Products |
|
|
|
|
|
|
|
|
|
|
Pfizer-BioNTech COVID-19 vaccine (mRNA)
All formulations
Show Links |
 |
|
|
|
|
|
|
|
|
|
|
|
Moderna COVID-19 vaccine (mRNA)
All formulations
Show Links |
 |
|
|
|
|
|
|
|
|
|
Janssen COVID-19 Vaccine (Johnson & Johnson) (viral vector)
Show Links |
 |
|
|
|
|
|
|
|
 |
Vaccine Fact Sheets (EUA, FDA-Licensed, and EUI) |
|
|
Fact Sheets for Pfizer-BioNTech COVID-19 Vaccines
Age 6 months through 4 years (maroon cap)
Show Links |
 |
|
|
|
|
|
|
|
|
|
Fact Sheets for Pfizer-BioNTech COVID-19 Vaccines
Age 5 through 11 years (orange cap)
Show Links |
 |
|
|
|
|
|
|
|
|
|
Fact Sheets for Pfizer-BioNTech COVID-19 Vaccines
Age 12 years and older – dilute before use (purple cap)
Show Links |
 |
|
|
|
|
|
|
|
|
|
|
|
 |
 |
Emergency Use Instructions (EUI) |
|
|
|
|
|
|
Fact Sheets for Pfizer-BioNTech COVID-19 Vaccines
Age 12 years and older – do not dilute (gray cap)
Show Links |
 |
|
|
|
|
|
|
|
|
|
|
|
 |
 |
Emergency Use Instructions (EUI) |
|
|
|
|
|
|
Fact Sheets for Moderna COVID-19 Vaccines
Age 6 months through 5 years (dark blue cap, magenta [pink] border)
Show Links |
 |
|
|
|
|
|
|
|
|
|
Fact Sheets for Moderna COVID-19 Vaccines
Age 6 through 11 years for primary series and age 18+ for 0.5 mL booster dose (dark blue cap, purple border)
This single formulation has separate EUA fact sheets for its use as a primary series dose in children age 6 through 11 years and for its use as a booster dose in adults 18+. The EUA fact sheets for age 6 through 11 years also reference packaging with a dark blue cap and teal border that is not yet available in the U.S.
Show Links |
 |
|
|
|
 |
 |
Age 6 through 11 years (primary series) |
|
|
|
|
|
|
|
|
 |
 |
Age 18+ years (booster dose) |
|
|
|
|
|
|
Fact Sheets for Moderna COVID-19 Vaccines
Age 12+ for primary series and age 18+ for 0.25 mL booster dose (red cap, light blue border)
Show Links |
 |
|
|
|
|
|
|
|
|
|
|
|
 |
 |
Emergency Use Instructions (EUI) |
|
|
|
|
|
|
Fact Sheets for Janssen (Johnson & Johnson) COVID-19 Vaccine
Show Links |
 |
|
|
|
|
|
|
|
|
|
COVID-19 Vaccine Emergency Use Instructions (EUI) Resources (CDC)
Show Links |
 |
|
|
|
|
|
 |
Clinic Resources and Tools |
|
|
|
|
General vaccine administration information |
 |
|
|
|
|
|
|
|
 |
 |
Prevaccination Checklist for COVID-19 Vaccines (CDC) [pdf] |
|
|
|
Translations:
Arabic,
Dari,
French (Canada),
Haitian Creole,
Korean,
Pashto,
Portuguese (Portugal),
Simplified Chinese,
Spanish,
Ukranian,
Vietnamese
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pfizer-BioNTech COVID-19 vaccine (mRNA)
All formulations |
 |
|
|
|
|
|
|
|
Pfizer-BioNTech COVID-19 vaccine (mRNA)
Age 6 months through 4 years |
 |
|
|
|
|
|
|
|
|
|
Pfizer-BioNTech COVID-19 vaccine (mRNA)
Age 5 through 11 years (orange cap) |
 |
|
|
|
|
|
|
|
Pfizer-BioNTech COVID-19 vaccine (mRNA)
Age 12 years and older – dilute before use (purple cap) |
 |
|
|
|
|
|
|
|
Pfizer-BioNTech COVID-19 vaccine (mRNA)
Age 12 years and older – do not dilute (gray cap) |
 |
|
|
|
|
|
|
|
Moderna COVID-19 vaccine (mRNA)
Age 6 months through 5 years (dark blue cap, magenta [pink] border) |
 |
|
|
|
|
|
|
|
Moderna COVID-19 vaccine (mRNA)
Age 6 through 11 years (dark blue cap, purple border) |
 |
|
|
|
 |
 |
Vaccine Preparation and Administration Summary: Moderna (n/a) |
|
|
|
|
|
|
Moderna COVID-19 vaccine (mRNA)
Age 12+ for primary series and age 18+ for 0.25 mL booster dose (red cap, light blue border) |
 |
|
|
|
|
|
|
|
|
|
Janssen COVID-19 Vaccine (Johnson & Johnson) (viral vector) |
 |
|
|
|
|
|
|
|
|
|
Clinical considerations for use of COVID-19 vaccines
Show Links |
 |
|
|
|
|
|
 |
COVID-19 Vaccines, Recommendations, and Schedules |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Safety |
 |
|
|
|
|
|
|
|
|
|
|
|
 |
Special Situations and Populations |
 |
|
|
|
|
|
|
|
|
|
|
|
 |
Appendices |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Severe Allergic Reactions |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Vaccine storage and handling (includes temperature logs)
Show Links |
 |
|
|
|
General storage and handling information |
 |
|
|
|
|
|
|
|
 |
 |
COVID-19 Vaccine Storage Temperature Logs |
|
|
 |
 |
Ultra-Cold Freezer (Pfizer-BioNTech vaccine) |
|
|
|
|
|
|
 |
 |
Freezer (Pfizer-BioNTech purple cap vaccine) |
|
|
|
|
|
|
 |
 |
Freezer (Moderna vaccine) |
|
|
|
|
|
|
 |
 |
Refrigerator (Pfizer-BioNTech, Moderna, and Janssen vaccines) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pfizer-BioNTech COVID-19 vaccine (mRNA)
All formulations |
 |
|
|
|
|
|
|
|
|
|
Pfizer-BioNTech COVID-19 vaccine (mRNA)
Age 6 months through 4 years (maroon cap) |
 |
|
|
|
|
|
|
|
|
|
|
|
Pfizer-BioNTech COVID-19 vaccine (mRNA)
Age 5 through 11 years (orange cap) |
 |
|
|
|
|
|
|
|
|
|
|
|
Pfizer-BioNTech COVID-19 vaccine (mRNA)
Age 12 years and older – dilute before use (purple cap) |
 |
|
|
|
|
|
|
|
|
|
|
|
Pfizer-BioNTech COVID-19 vaccine (mRNA)
Age 12 years and older – do not dilute (gray cap) |
 |
|
|
|
|
|
|
|
|
|
|
|
Moderna COVID-19 vaccine (mRNA)
All formulations |
 |
|
|
|
|
|
Moderna COVID-19 vaccine (mRNA)
Age 6 months through 5 years (dark blue cap, magenta [pink] border) |
 |
|
|
|
|
|
|
|
|
|
Moderna COVID-19 vaccine (mRNA)
Age 6 through 11 years (dark blue cap, purple border) |
 |
|
|
|
|
|
 |
 |
Beyond-Use Date (BUD) Tracking Labels for Vaccine During Freezer or Refrigerator Storage: Moderna (n/a) |
|
|
Moderna COVID-19 vaccine (mRNA)
Age 12+ for primary series and age 18+ for 0.25 mL booster dose (red cap, light blue border) |
 |
|
|
|
|
|
|
|
|
|
|
|
Janssen COVID-19 Vaccine (Johnson & Johnson) (viral vector) |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Vaccine Provider Information |
|
|
|
|
|
|
|
|
|
|
|
|
 |
Considerations for Vaccination of Special Populations |
|
|
|
|
|
|
 |
Reimbursement |
|
|
|
|
|
|
|
|
|
|